# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055661
Filing Date
2024-05-08
Accepted
2024-05-08 16:11:16
Documents
104
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | mnkd-20240331.htm iXBRL | 10-Q | 2432356
2 | EX-31.1 | mnkd-ex31_1.htm | EX-31.1 | 13644
3 | EX-31.2 | mnkd-ex31_2.htm | EX-31.2 | 13643
4 | EX-32.1 | mnkd-ex32_1.htm | EX-32.1 | 9650
5 | EX-32.2 | mnkd-ex32_2.htm | EX-32.2 | 9662
| Complete submission text file | 0000950170-24-055661.txt |  | 13035944

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | mnkd-20240331.xsd | EX-101.SCH | 2328442
108 | EXTRACTED XBRL INSTANCE DOCUMENT | mnkd-20240331_htm.xml | XML | 2296954

Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 24926136
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)